Alveolar macrophages (AMs) play important roles in the pathogenesis of chronic obstructive pulmonary disease (COPD). We previously demonstrated upregulation of the transcription factor MafB in AMs of mice exposed to cigarette smoke. The aim of this study was to elucidate the roles of MafB in the development of pulmonary emphysema. Porcine pancreatic elastase was administered to wild-type (WT) and dominant-negative (DN)-MafB transgenic (Tg) mice in which MafB activity was suppressed only in macrophages. We measured the mean linear intercept and conducted cell differential analysis of bronchoalveolar lavage (BAL) cells, surface marker analysis using flow cytometry, and immunohistochemical staining using antibodies to matrix metalloproteinase (MMP)-9 and MMP-12. Airspace enlargement of the lungs was suppressed significantly in elastase-treated DN-MafB Tg mice compared with treated WT mice. AMs with projected pseudopods were decreased in DN-MafB Tg mice. The number of cells intermediately positive for F4/80 and weakly or intermediately positive for CD11b, which are considered cell subsets of matured AMs, decreased in the BAL of DN-MafB Tg mice. Furthermore, MMP-9 and -12 were significantly downregulated in BAL cells of DN-MafB Tg mice. Because MMPs exacerbate emphysema, MafB may be involved in pulmonary emphysema development through altered maturation of macrophages and MMP expression.
Introduction
Chronic obstructive pulmonary disease (COPD) is the fourth cause of death worldwide [1] . Pulmonary emphysema is a representative type of COPD and pathologically characterised by the enlargement of alveoli in the lung. Pulmonary emphysema is thought to be caused by chronic inflammation induced by increased numbers of inflammatory cells releasing potentially destructive mediators, namely matrix metalloproteinases (MMPs) [2, 3] . Of inflammatory cells, the numbers of alveolar macrophages (AMs) increase in the lungs of COPD patients [4] . AMs play important roles in the pathogenesis and pathophysiology of pulmonary emphysema [5, 6] .
We previously demonstrated that the transcription factor MafB was upregulated in AMs in the lungs of mice with cigarette smoke-induced pulmonary emphysema [7] . In addition, we reported that the intensity of immunostaining of MafB in AMs correlated with the degree of airflow limitation in human smokers [8] . MafB, also known as V-maf musculoaponeu-
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International Publisher rotic fibrosarcoma oncogene homolog B, is a member of the Maf protein family and possesses a basic leucine zipper structure at the carboxyl terminus. MafB is expressed only in monocytes and macrophages among hematopoietic cells, and it plays an important role in the terminal differentiation of macrophages [9] . MafB forms a homodimer and binds Maf recognition element (MARE) to transactivate the transcription of MARE regulated genes [10] . A truncated form of MafB lacking an N-terminal acidic domain reportedly acts in a dominant negative (DN) manner [9] . DN MafB forms heterodimers with endogenous MafB and inhibits the binding of endogenous MafB homodimers with MARE. In addition, it was demonstrated that MafB binds the MARE motif in the promoter region of the MMP-9 gene and up-regulates MMP-9 in macrophages [11] .
MafB knockout mice die immediately after birth due to developmental anomalies of neurons in the respiratory centre [12, 13] . Thus, the role of MafB in the pathogenesis of pulmonary emphysema has not been fully investigated in vivo due to the lack of an adequate animal model. To explore the role of MafB in COPD, we generated transgenic mice that express DN MafB capable of suppressing endogenous MafB transcription activity only in macrophages [14] . These transgenic mice had a similar survival rate compared with WT mice and enabled us to generate an adequate emphysema mouse model.
The elastase-induced emphysema model is a conventional experimental emphysema model. Elastase is a serine protease that has the capability of digesting elastin. Elastin is one of the major component proteins of the lung, and intratracheal administration of elastase is known to cause airspace enlargement in the lungs of experimental animals [15, 16] . It takes for 3 or 4 weeks to induce pulmonary emphysema in the lungs of mice, and inflammatory mediators and endogenous MMPs from accumulated macrophages are thought to play a principal role in that emphysematous change [17] [18] [19] . Administration of macrophage-colony stimulating factor, which induces MMP-9 and -12 expression in AMs, following elastase intratracheal administration augments the development of pulmonary emphysema more than saline administration following elastase treatment, which suggests that MMPs play important roles in animal models of elastase-induced pulmonary emphysema [18] . Because this model is suited to investigate the function of macrophages in emphysema, we applied the elastase-induced emphysema model to DN-MafB Tg mice and investigated the role of MafB in the pathogenesis of pulmonary emphysema.
Methods

Mice
As described previously, we have established the macrophage scavenger receptor enhancer-promoter dominant-negative MafB transgenic (DN-MafB Tg) mice on the C57/BL6 background in which the activity of MafB was suppressed only in macrophages [14] . Eight-to twelve-week-old male mice and wild-type (WT) control mice, purchased from CLEA Japan (Tokyo, Japan), were used in these experiments. The study was approved by the Committee for Animal Experimentation, Yamagata University School of Medicine and was carried out in accordance with the Declaration of Helsinki.
An emphysematous model
Mice were anaesthetised with an intraperitoneal injection of pentobarbital sodium (150 mg/kg body weight). Porcine pancreatic elastase (PPE; Sigma-Aldrich, St Louis, MO, USA) in saline was administered at a dose of 1.5 U/100 μL using a MicroSprayer aerosoliser (1A-1C; Penn-Century, Philadelphia, PA, USA) attached to a high-pressure syringe (FMJ-250; Penn-Century). Control mice were treated similarly but with 100 μl of saline only. After 7 d and 21 d of treatment, the mice were sacrificed for lung fixation and for bronchoalveolar lavage (BAL) analysis.
Lung fixation and morphometry
After intraperitoneal injection of pentobarbital, the animals were exsanguinated by cutting the distal aorta. The lungs were fixed intratracheally with buffered formalin (4%) at a constant pressure of 25 cm H 2 O to prepare paraffin-embedded lung blocks. These sections were subsequently stained with hematoxylin and eosin or Elastica van Gieson. In the lungs after 21 d of PPE administration, the mean linear intercept (MLI), as a measure of the interalveolar septal wall distance, was measured using a light microscope at a magnification of ×200. The MLI was obtained by dividing the length of a line drawn across the lung section by the total number of intercepts encountered in 50 lines per mouse lung, as described previously [20, 21] .
BAL
BAL was performed by infusing 1 mL of Hanks' balanced salt solution (HBSS) with 0.5 mM ethylenediamine tetraacetic acid five times via a 20-gauge catheter inserted into the trachea. The BAL fluid was centrifuged at 1200 rpm for 5 min. The BAL cells were fixed on slides by subjecting the BAL fluid to a cytospin of 1000 rpm for 5 min and subsequently stained with a Diff-Quick solution (International Reagents Corp., Kobe, Japan) for differential cell counts.
Evaluation of the shape of AMs
To examine whether AM shape alteration occurred in the DN-MafB Tg mice, we divided macrophage lineage cells into three types in accordance with optical microscope findings: macrophages with projected pseudopods, macrophages without projected pseudopods (not recognised with an optical microscope), and alveolar monocyte-like cells. Alveolar monocyte-like cells exhibited a smaller cellular size and less cytoplasmic granularity than differentiated macrophages but were bigger than lymphocytes. One-hundred cells were classified in each mouse.
Immunohistochemistry of AMs
Cytospun BAL cells were fixed with an acetone/methanol (1:1) solution and incubated with Mac-3 (Becton, Dickinson and Company, San Diego, CA, USA; diluted 1:100), CD11c (Abcam, Cambridge, MA, USA; diluted 1:50), metalloproteinase (MMP)-9, or MMP-12 (Santa Cruz Biotechnology, Santa Cruz, CA, USA; diluted 1:50, 1:100, respectively) antibodies and then secondary antibodies. Nuclei were counterstained with hematoxylin in the immunohistochemical analysis of MMP-9 and MMP-12.
Flow cytometry
AM cell surface markers (F4/80, CD11b and CD11c) were analysed using flow cytometry. The BAL cells were recovered from untreated mice or mice 7 d after PPE administration. Cells were resuspended in fluorescence-activated cell sorter (FACS) buffer (PBS, 0.2% BSA, 0.01% sodium azide). Erythrocytes were haemolysed before analysis. The BAL cells were stained with FITC-labelled F4/80 antibody (AbD serotec), PerCP-cy5.5-labelled CD11b antibody (Becton, Dickinson and Company), PerCP-cy5.5-labelled CD11c antibody (Becton, Dickinson and Company), PE-labelled Gr-1 antibody (Becton, Dickinson and Company), or an isotype control (Becton, Dickinson and Company) at 4°C for 30 min. The stained cells were subjected to flow cytometry using a FACS Canto II flow cytometer (BD Biosciences). To avoid the contamination of neutrophils in the study, Gr-1 positive cells were omitted from the analysis. For the analyses of cells 7 d after PPE administration, Gr-1 negative cells were divided into three groups based on their F4/80 and CD11b fluorescence intensity. The evaluation of these surface markers was performed based on the ratio of each of the three groups to all Gr-1 negative cells. For analyses of cells from untreated mice, the fluorescence intensity of CD11c in Gr-1 negative and F4/80-positive cells were assessed in TG and control mice. Data were analysed using DIVA software (BD Bioimaging systems, MD, USA).
Biochemical analysis of BAL fluid
Murine TNF-alpha and IL-6 in the BAL fluid were measured by ELISA (Quantikine; R&D Systems, Minneapolis, MN, USA) according to the manufacturer's instructions.
Reverse transcription (RT)-PCR
Total RNA of AMs was isolated using an RNeasy Mini Kit (QIAGEN, Valencia, CA, USA) according to the manufacturer's protocol. RT was performed using SuperScript III (Invitrogen). The sequences of the specific primers were: MafB forward, CGT CCA GCA GAA ACA TCA CC; reverse, TCG CAC TTG ACC TTG TAG GC; GAPDH forward, CTT CAC CAC CAT GGA GAA GGC; reverse, GGC ATG GAC TGT GGT CAT GAG. PCR products were electrophoresed in 1.5% agarose gels containing ethidium bromide and visualized digitally on a UV illuminator (AB1500 Printgraph and AE 6905H Image Saver HR; ATTO Bioscience, Tokyo, Japan) [14] .
Establishment of macrophage cell line constitutively expressing MafB short hairpin (sh)-RNA
The MafB sh-RNA plasmid and control scrambled-sequence sh-RNA plasmid vector were generated by inserting the double-strand oligonucleotide (MafB sh-RNA sense, GCC TAC AAG GTC AAG TGC GAG AAA CTC GCC; MafB sh-RNA antisense, GGC GAG TTT CTC GCA CTT GAC CTT GTA GGC; control sh-RNA sense, GCG AGA CAA CCA GTG AAC TGG TCT AAC GCC; control sh-RNA antisense, GGC GTT AGA CCA GTT CAC TGG TTG TCT CGC) into piGENE TM tRNApuro (Takara, Tokyo, Japan) according to the manufacturer's protocol. Constitutive expression of MafB sh-RNA was achieved by transfection of RAW264.7 cells with a plasmid vector expressing sh-RNA MafB by GenePORTER2 (Gene Therapy Systems Inc., San Diego, CA) [7] . As a transfection control, a scrambled-sequence sh-RNA plasmid was transfected into RAW264.7 cells. Antibiotic selection with puromycin (10 µg/ml) was started 48 h after transfection. After 10-20 days in selection medium, the cells were subjected to a limiting dilution method to obtain MafB-repressing clones. Expression of MafB in each clone was examined using RT-PCR. From all 45 clones, the most suppressive clone was selected as MafB-repressing cells. These cells were designated as RAW264.7-MafB-shRNA, whereas control cells were named RAW264.7-control-shRNA.
Activity of nuclear factor-kappa B (NF-kB) and activator protein (AP)-1
hRNA cells were treated with porcine pancreatic elastase at the concentration of 100 mU/mL in Dulbecco's Modified Eagle Medium containing 10% foetal bovine serum for 30 min in a 5% CO 2 incubator. Nuclear protein was isolated from these cells using Nuclear Extract Kit (Active Motif, Carlsbad, CA) according to manufacturer's protocol, and 10 ng of nuclear protein was used to assess the activity of NF-kB p65 and AP-1, c-fos, using TransAM ® NFκB Family Transcription Factor ELISA Kit (Active Motif, Carlsbad, CA).
Statistical analyses
The Kruskal-Wallis test for nonparametric data was used to analyse the difference between the three groups. The results are expressed as the mean ± standard deviation. Significance was inferred for P values < 0.05. Statistical analyses were performed using JMP 9.0 computer software (SAS Institute, Inc., Cary, NC, USA).
Results
Suppression of emphysematous change in the lungs of elastase-treated DN-MafB Tg mice
The airspaces of the WT mice 21 d after PPE administration were larger than those of the saline-treated control mice (Figure 1a) . However, this airspace enlargement was suppressed in the lungs of PPE-treated DN-MafB Tg mice. Furthermore, the elastic fibres, including elastin, maintained their structure in the lungs of PPE-treated DN-MafB Tg mice compared with those of the PPE-treated WT mice ( Figure  1b) . The MLI, which represents the quantification of airspace enlargement, was reduced significantly in the lungs of the DN-MafB Tg mice compared with that of the control mice (P < 0.05) (Figure 2 ).
BAL cells of DN-MafB Tg mice
To evaluate the change in the total cell number and cell fraction, BAL was performed on Day 0, Day 7, and Day 21 after PPE treatment (Figure 3 and Table 1). On Day 7, total cell count, as well as the number of macrophages, neutrophils, and lymphocytes increased in both WT and Tg mice (Figure 3a and 3b and Table 1 ). In both WT and Tg mice, the total cell number on Day 21 was lower than that on Day 7, and the cell fraction almost returned to the basal level. However, the total cell number and cell fraction in the BAL cells of the DN-MafB Tg mice were not significantly different from those of the WT mice (Table 1 and Figure 3b ). 
Morphological changes in the AMs of DN-MafB Tg mice
We previously demonstrated that the shapes of pseudopods on the AMs of DN-MafB Tg mice were altered and that alveolar monocyte-like cells were increased in the BAL cells of untreated DN-MafB Tg mice [14] . Therefore, we divided macrophage lineage cells into three types based on their shapes and sizes: macrophages with projected pseudopods, macrophages without projected pseudopods, and alveolar monocyte-like cells (Figure 4a ). First, we subjected cytospun BAL cells to immunostaining using a Mac-3 antibody to distinguish alveolar monocyte-like cells from lymphocytes according to their positivity for Mac-3 ( Figure 4b ). All three types of cells were positive for Mac-3, confirming that these cells are macrophages. To determine whether these cells have characteristics similar to those to alveolar macrophages, immunohistochemistry for CD11c, a surface marker for alveolar macrophages, was performed. As shown in Figure 4c , most alveolar macrophages in TG mice maintained CD11c expression. To confirm this finding, we performed FACS analysis. As shown in the Figure 4d , the immunoreactivity of CD11c in alveolar macrophages (Gr-1 negative-and F4/80 positive-cells) was not different between TG and wild-type mice, suggesting that these alveolar macrophages in DN-MafB mice maintain one of the typical characteristics of alveolar macrophages [22, 23] . Figure 5 displays the results of the classification of the macrophage lineage cells. On Day 0, the macrophage lineage cells were primarily macrophages without projected pseudopods (Figure 5b) . On Day 7, all of the macrophage lineage cells had accumulated in the lungs of both the Tg and control mice. However, the number of macrophages with projected pseudopods in the Tg mice was significantly lower than those of the control mice on Day 7 (Figure 5a ). The number of macrophages with projected pseudopods was not different between the two groups on Day 0 and Day 21 (Figure 5a ). The number of macrophages without projected pseudopods was not different between the WT mice and the DN-MafB Tg mice during the observation period (Figure 5b ). The number of alveolar monocyte-like cells on Day 7 increased in both the WT mice and the DN-MafB Tg mice, but no difference was observed between the two groups ( Figure 5c ).
Alteration of macrophage surface markers in DN-MafB Tg mice
To assess whether the maturation of AMs was altered in the DN-MafB Tg mice, we examined the expression of CD11b and F4/80 on AMs on Day 7 after treatment using flow cytometric analysis. 
Suppression of immunostaining intensity of MMPs in AMs of DN-MafB Tg mice
Cytospun BAL cells were immunohistochemically stained using antibodies to MMP-9 and MMP-12 on Day 0 and Day 7 ( Figure 7) . On Day 0, there were few MMP-9-and MMP-12-positive cells in both WT and DN-MafB Tg mice. On Day 7, MMP-9-positive and MMP-12-positive cells were observed commonly in the WT mice; however, these positive cells were decreased in the DN-MafB Tg mice. 
TNF-alpha and IL-6 production in DN-MafB Tg mice
To assess the degree of inflammation in this mouse model, the concentrations of TNF-alpha and IL-6, which are both important for pathogenesis of COPD clinically and experimentally [19, [24] [25] [26] [27] [28] , were measured in the BAL fluid obtained from the WT and DN-MafB Tg mice on Day 0, Day 7, and Day 21 (Figure 8) . Both the TNF-alpha and IL-6 concentrations were elevated on Day 7. However, the levels of TNF-alpha and IL-6 remained low, and there was no significant difference between the WT and DN-MafB Tg mice.
Intratracheal administration of pancreatic elastase induced MafB gene expression in alveolar macrophages of wild type mice.
We investigated whether intratracheal administration of pancreatic elastase induces MafB gene expression in alveolar macrophages of wild-type mice by RT-PCR. MafB was upregulated in wild-type mice 7 days after intratracheal administration of elastase ( Figure 9 ). Because MMP gene expression is known to be regulated by transcription factors such as nuclear factor kappa B (NF-kB) and activated protein (AP)-1 [29] [30] [31] [32] [33] , we investigated whether MafB is associated with the activity of these transcription factors using a macrophage cell line in which MafB gene expression is constitutively supressed by MafB sh-RNA (RAW264.7 MafB-shRNA; Figure 10a ). Elastase treatment significantly increased NF-kB p65 activity in both control (R264.7-control-shRNA) and MafB-shRNA cells, but there was no difference in the level of p65 activity between the two groups. In contrast, the activity of c-fos, a component of AP-1, was not enhanced by elastase treatment in both cell types.
Under the resting condition, the c-fos activity of RAW264.7-MafB-shRNA cells was significantly supressed relative to that in control cells. After stimulation by elastase, the difference in c-fos activity between RAW264.7 MafB-shRNA and control cells was not statistically significant, but c-fos activity tended to be suppressed in elastase-stimulated RAW264.7 MafB-shRNA cells relative to control cells (P =0.052, Figure 10b ).
Discussion
AMs play an important role in the pathogenesis of COPD [4] , release inflammatory mediators, and induce prolonged inflammation and alveolar destruction in the lungs. The inflammatory mediators include TNF-alpha, IL-1beta, IL-6, and MMPs. We previously demonstrated that MafB was upregulated in AMs in the lungs of mice with cigarette smoke-induced emphysema, suggesting a relationship between cigarette smoking and MafB in AMs [7] . In addition, we reported that the intensity of MafB immunostaining in AMs was correlated with the degree of airflow limitation in human smokers [8] . In the present study, we generated an elastase-induced emphysema model in DN-MafB Tg mice, which exhibit reduced macrophage MafB activity, and demonstrated that an emphysematous change was suppressed significantly in the DN-MafB Tg mice (Figure 1 and 2) . In addition, elastase instillation into the lungs of wild-type mice increased the expression of MafB (Figure 9 ). Therefore, the present study indicates an important role of MafB for the development of emphysema induced by intratracheal administration of elastase. Generation of MafB short hairpin (sh) RNA-expressing cell line and assessment of nuclear factor-kappa B (NF-kB) p65 and c-fos activity in resting and elastase-stimulated conditions. A) RAW264.7-MafB-shRNA and RAW264.7-control-shRNA cells were generated as described in the Methods. In RAW264.7-MafB-shRNA cells, MafB gene expression was one fifth of that in RAW264.7-control-shRNA cells. b) Elastase treatment significantly enhanced NF-kB p65 activity in both control (R264.7-control-shRNA) cells and MafB-shRNA cells, but there was no difference in the level of p65 activity between the two cell types. In contrast, activity of c-fos, a component of AP-1, was not enhanced by elastase treatment in both cell types. In the resting condition, the c-fos activity in RAW264.7-MafB-shRNA cells was significantly supressed relative to that in control cells. After stimulation by elastase, the difference in c-fos activity between RAW264.7 MafB-shRNA and control cells was not statistically significant, but c-fos activity tended to be suppressed in elastase-stimulated RAW264.7 MafB-shRNA cells relative to control cells (P =0.052).
MafB is known as a regulator of macrophage differentiation [9] and other various developmental processes, such as segmentation in the hindbrain [34] , islet beta-cell differentiation [35] , and chondrocyte differentiation [36] . Zhang et al. reported that retinoic acid-induced MMP-3 and MMP-13 gene expression was attenuated in MafB-knockdown chondrocytes [36] . MMP-3 and MMP-13 are induced in terminally differentiated chondrocytes, and MMP-12 is produced by differentiated macrophages [37] . Because the production of MMPs may partly depend on cellular differentiation and maturation, which MafB can regulate, we examined the expression of F4/80 and CD11b to evaluate the maturation of AMs in DN-MafB Tg mice. F4/80 is a specific cell surface marker for murine macrophages [38, 39] . CD11b is widely expressed on the surface of monocytes, macrophages, NK cells, and granulocytes. The number of F4/80med CD11b low/med cells was decreased in the BAL cells of DN-MafB Tg mice compared to the BAL cells of WT mice by Day 7 after PPE administration ( Figure 6 ).
AMs present lower expression of CD11b than other macrophage-lineage cells, such as interstitial macrophages, dendritic cells, and monocytes [40, 41] . Thus, F4/80med CD11b low/med cells were considered to be mature AMs. Our data suggest that the number of maturated AMs after elastase-induced inflammation is reduced in DN-MafB Tg mice.
Pseudopods on AMs of DN-MafB Tg mice have been reported to have a 'lamellipodium-like' shape, as determined by electron microscopy. In addition, actin filament formation was shown to be attenuated in the pseudopods of AMs of DN-MafB Tg mice [14] . Although no morphological changes were observed in the BAL cells of untreated DN-MafB Tg mice with an optical microscope, the number of macrophages with projected pseudopods decreased significantly in the DN-MafB Tg mice by Day 7 after elastase administration. Macrophages with projected pseudopods are considered to be activated AMs [42] . Therefore, our results suggest that the number of activated AMs by Day 7 after elastase administration was decreased in DN-MafB Tg mice relative to WT mice.
Pulmonary emphysema is pathologically characterized by the enlargement of alveoli in the lung. Among inflammatory mediators from AMs, MMPs are believed to play important roles in the development of emphysema by degrading the extracellular matrix in the lung. MMPs are a family of zinc-dependent proteinases capable of degrading the extracellular matrix. Even in the murine model of pulmonary emphysema induced by a single instillation of porcine pancreatic elastase, subsequent production of MMPs from AMs is considered to be important for disease development [18] . MMP-12 is believed to play an important role in the development of emphysema by degrading the extracellular matrix in the lung. Elastin, the major target protein of MMP-12, is downregulated in the lung parenchyma of emphysema patients [43] . It has been reported that the expression of MMP-12 is higher in COPD patients than in control subjects, both in BAL samples and bronchial biopsies [44] , and that MMP-12-deficient mice do not develop air space enlargement in response to smoke exposure [45] .
In the present study, the expression of MMP-12 in BAL cells was reduced significantly in DN-MafB Tg mice (Figure 7) , and elastase-induced pulmonary emphysema was suppressed in DN-MafB Tg mice (Figure 2 ). Based on previous reports, the decrease of MMP-12 levels in DN-MafB Tg mice could attenuate the airspace enlargement of the lung in this elastase-induced emphysema. MafB directly regulates the expression of MMP-9 through binding to the MARE motif in its promoter region [11] . In addition, the results using macrophage cell line in this study ( Figure  9 ) suggests that MafB is associated with the activity of AP-1 that is important for MMP expression [29, 31] . Thus, MafB may be indirectly associated with the development of elastase-induced pulmonary emphysema through regulation of the activity of AP-1. However, the mechanisms underlying suppression of MMP expression by DN-MafB have not been fully elucidated. Future experiments should therefore investigate how the transcription factor MafB regulates the expression of MMPs.
The changes in the extent of inflammation after elastase administration in the lungs of DN-MafB Tg mice compared to wild-type mice may be another conceivable reason for the decrease of MMP-12 levels. The activity of MMP-12 is known to be stimulated by inflammatory cytokines such as TNF-alpha and IL-6 [46, 47] . We assessed the concentrations of TNF-alpha and IL-6 in elastase-administered DN-MafB Tg mice, and the concentrations were not different from those in the elastase-administered WT mice (Figure 8 ). In addition, the levels of proinflammatory cytokines remained low even by Day 7 of PPE treatment. One limitation of our study is that we did not assess these cytokines in the acute inflammatory phase. However, the majority of airspace enlargement in this model is believed to occur in the chronic inflammatory phase [19] . Therefore, inhibition of inflammatory cytokines does not seem to play an important role in the suppression of MMPs in elastase-treated DN-MafB Tg mice.
Another limitation of the present study is that we did not evaluate the effect of cigarette smoke exposure in the Tg mice. Because animal models using cigarette smoke exposure are thought to be more similar to human pulmonary emphysema, future studies should use animal smoking models. In addition, an experiment transplanting mature macrophages from wild-type mice to DN-MafB mice by adoptive transfer may shed light on the mechanism underlying the inhibition of elastase-emphysema in the Tg mice. However, the efficacy of adoptive transfer does not seem sufficient for such an experiment [40] .
In conclusion, the present study demonstrated that DN-MafB suppressed elastase-induced pulmonary emphysema development by altering the production of MMPs; therefore, MafB may play an important role in the pathogenesis of pulmonary emphysema via alveolar macrophage maturation.
